CBD Sex-and-BMI Plots Were Exploratory Rather Than Proven Covariate Effects
The hemp cosmetic trial displayed CBD profiles by sex and body-mass-index category, but expressly treated those plots as descriptive. Visual differences did not establish a validated dose-adjustment rule.
The study was small and unevenly distributed
Twenty healthy adults enrolled and eighteen completed both periods. Most completers were women, and the authors supplied concentration-time plots stratified by sex and BMI range. These displays can reveal patterns worth investigating, but subgroup sizes and the study’s exploratory purpose constrain inference.
A plot is not a formal covariate analysis
The paper states that the subgroup figures were intended to generate hypotheses rather than support formal covariate inference. A visible separation between curves does not, by itself, establish a statistically supported effect, explain its mechanism or exclude other differences between the people represented.
Clinical dosing needs stronger support
The results do not establish that men, women or people in a particular BMI range need a specified multiplier of CBD. Nor does a lack of a formal subgroup conclusion prove identical exposure across those groups. The distinction is between observing variation and estimating a dependable predictor of that variation. Future research can use the plots to plan balanced sampling and prespecified analyses. For current interpretation, the supported route comparison and the descriptive subgroup observations should remain separate. This was a pharmacokinetic study in selected healthy adults, not a dosing algorithm validated across ages, illnesses and concomitant treatments.
Related analysis: interpreting the study’s urine and plasma findings.
Research cited
Jain and colleagues. Results of an Exploratory Crossover Pharmacokinetic Study Evaluating a Natural Hemp Extract-Based Cosmetic Product: Comparison of Topical and Oral Routes of Administration. Pharmaceuticals (2026). DOI: 10.3390/ph19020231.
